View Financial HealthEvonik Industries 配当と自社株買い配当金 基準チェック /46Evonik Industriesは配当を支払う会社で、現在の利回りは5.81%です。次の支払い日は 8th June, 2026で、権利落ち日は4th June, 2026 。主要情報5.8%配当利回り0%バイバック利回り総株主利回り5.8%将来の配当利回り4.7%配当成長0.2%次回配当支払日08 Jun 26配当落ち日04 Jun 26一株当たり配当金n/a配当性向296%最近の配当と自社株買いの更新Declared Dividend • Feb 07Dividend reduced to €1.00Dividend of €1.00 is 15% lower than last year. Ex-date: 4th June 2026 Payment date: 8th June 2026 Dividend yield will be 6.7%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to decline by 19% over the next 3 years. A fall of 18% would increase the payout ratio to a potentially unsustainable range, which means the dividend may be at risk.お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.Upcoming Dividend • May 22Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 29 May 2025. Payment date: 03 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (3.9%).Declared Dividend • Mar 07Dividend of €1.17 announcedDividend of €1.17 is the same as last year. Ex-date: 29th May 2025 Payment date: 2nd June 2025 Dividend yield will be 5.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is not covered by earnings (246% earnings payout ratio). However, it is covered by cash flows (62% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 173% to bring the payout ratio under control. EPS is expected to grow by 158% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.0%).すべての更新を表示Recent updates分析記事 • May 15There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) EarningsEvonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...お知らせ • May 12Vary Tech, Evonik and Supezet Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality Ppo and Circular NaphthaVary Tech, a global leader in solid waste resource utilization, together with Evonik and SupeZET, officially launched a full-industry chain process package for chemically recycling waste plastics into high-quality Plastic Pyrolysis Oil (PPO) and circular naphtha. The core technology is Vary Tech's oxygen-free pyrolysis, developed over 20 years and six iterations. With a single-unit capacity of 150 tons/day and over 8,000 operating hours annually, it ensures high front-end stability. The PPO then enters Evonik's proprietary Rocket module for upgrading and impurity removal, followed by SupeZET's advanced hydrogenation and fractionation for deep refining. The complete chain — feedstock pretreatment, continuous pyrolysis, deep purification, and product offtake — directly outputs circular naphtha and high-quality PPO meeting international petrochemical standards. This ensures seamless entry into global petrochemical and low-carbon fuel supply chains, removing technical barriers to the high-end circular economy. As the core engine, Vary Tech's oxygen-free pyrolysis technology offers broad feedstock compatibility. Beyond waste plastics, it has been applied to waste tires, oil sludge, industrial hazardous waste, medical waste, and new energy solid waste, with over 100 commercial pyrolysis lines delivered globally. While building chemical recycling, Vary Tech also leads in mechanical recycling. Leveraging 16 years of self-operated plant experience and its "high-end equipment manufacturing + industrial operation" dual-drive model, Vary Tech showcased its AI-powered intelligent home appliance dismantling system at the exhibition. Achieving 200 units per hour — a global efficiency record — the system delivers high-purity separation of all e-waste categories. Vary Tech has empowered Haier, TCL, and Midea, providing green recycling services for over 130 million obsolete appliances worldwide. From mechanical to chemical recycling, Vary Tech is integrating global supply chain resources to deliver scalable, economical, and sustainable technical solutions for global climate action and circular economy goals.Reported Earnings • May 11First quarter 2026 earnings released: EPS: €0.27 (vs €0.50 in 1Q 2025)First quarter 2026 results: EPS: €0.27 (down from €0.50 in 1Q 2025). Revenue: €3.43b (down 9.3% from 1Q 2025). Net income: €125.0m (down 46% from 1Q 2025). Profit margin: 3.6% (down from 6.2% in 1Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.ライブニュース • May 07Evonik Industries Stock Plunges 51% as Investors Await Crucial Earnings ReportEvonik Industries stock dropped 50.8% intraday on 5 May, reflecting a sharp loss of confidence ahead of its upcoming earnings release. The move highlights investor concern over profitability, operational headwinds and the resilience of the current dividend policy. The 8 May earnings announcement is seen as a key test of management’s outlook and plans through 2026. For you as an investor, the price shock signals that the market is bracing for potentially weak numbers or a reset in expectations, but without the earnings release yet, the exact triggers are not clear. The focus now is on whether management can provide a detailed picture of operational performance and explain how current conditions affect margins, cash flow and the dividend. The 2026 guidance will be especially important because it should show how Evonik plans to position its portfolio and manage costs over the medium term. Pay close attention to any commentary on capital allocation, possible changes to the payout, and the balance between investment and balance-sheet protection. This earnings call is likely to set the tone for how the stock is viewed until there is more concrete financial information.ナラティブの更新 • May 03EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re RatingAnalysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.ナラティブの更新 • Apr 19EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating PotentialAnalysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.お知らせ • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.ナラティブの更新 • Apr 03EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share PerformanceAnalysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €16.28, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 1.3% over the past three years.ナラティブの更新 • Mar 20EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating PotentialThe analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.New Risk • Mar 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 43% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (176% payout ratio). Large one-off items impacting financial results.ナラティブの更新 • Mar 06EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker ViewsAnalysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.ナラティブの更新 • Feb 20EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.Declared Dividend • Feb 07Dividend reduced to €1.00Dividend of €1.00 is 15% lower than last year. Ex-date: 4th June 2026 Payment date: 8th June 2026 Dividend yield will be 6.7%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to decline by 19% over the next 3 years. A fall of 18% would increase the payout ratio to a potentially unsustainable range, which means the dividend may be at risk.New Risk • Feb 06New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 5.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.3% per year for the foreseeable future. Minor Risks High level of debt (45% net debt to equity). Dividend is not well covered by earnings (dividend per share is over 5x earnings per share).Reported Earnings • Feb 06Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €1.36 (up from €0.48 in FY 2024). Revenue: €14.1b (down 7.2% from FY 2024). Net income: €634.0m (up 186% from FY 2024). Profit margin: 4.5% (up from 1.5% in FY 2024). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.ナラティブの更新 • Feb 06EVK: Weaker Pricing Power Will Drive Lower Future Earnings ExpectationsAnalysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.分析記事 • Feb 06Evonik Industries AG (ETR:EVK) Not Flying Under The RadarWhen close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...ナラティブの更新 • Jan 23EVK: Sector Caution And Margin Execution Will Shape Future Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.ナラティブの更新 • Jan 08EVK: Pricing And Volume Execution Risk Will Pressure Future EarningsAnalysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.ナラティブの更新 • Dec 23EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside PotentialEvonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.ナラティブの更新 • Dec 09EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside PotentialThe analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.分析記事 • Dec 04Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...ナラティブの更新 • Nov 24EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform CollaborationEvonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.Price Target Changed • Nov 11Price target decreased by 10% to €16.45Down from €18.37, the current price target is an average from 13 analysts. New target price is 19% above last closing price of €13.80. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.76 for next year compared to €0.48 last year.Major Estimate Revision • Nov 11Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.994 to €0.761 per share. Revenue forecast steady at €14.0b. Net income forecast to grow 351% next year vs 33% growth forecast for Chemicals industry in Germany. Consensus price target down from €17.63 to €16.45. Share price fell 3.6% to €13.80 over the past week.New Risk • Nov 06New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 5x earnings per share. Cash payout ratio: 120% Minor Risks High level of debt (45% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).ナラティブの更新 • Nov 06EVK: Resilience And New Partnerships Will Drive Improved Revenue OutlookEvonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.お知らせ • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026Reported Earnings • Nov 05Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: €0.23 loss per share (down from €0.48 profit in 3Q 2024). Revenue: €3.39b (down 12% from 3Q 2024). Net loss: €106.0m (down 148% from profit in 3Q 2024). Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 8% per year.分析記事 • Oct 30Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of InvestorsWith a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...ナラティブの更新 • Oct 23Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic MovesEvonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.ナラティブの更新 • Oct 09Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.お知らせ • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026Price Target Changed • Sep 26Price target decreased by 7.0% to €18.91Down from €20.34, the current price target is an average from 13 analysts. New target price is 29% above last closing price of €14.69. Stock is down 31% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €0.48 last year.お知らせ • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.ナラティブの更新 • Sep 25Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.分析記事 • Sep 13Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...ナラティブの更新 • Sep 04Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityWith both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.分析記事 • Aug 28At €16.68, Is It Time To Put Evonik Industries AG (ETR:EVK) On Your Watch List?Evonik Industries AG ( ETR:EVK ), is not the largest company out there, but it saw significant share price movement...Reported Earnings • Aug 03Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: €0.26 (up from €0.011 loss in 2Q 2024). Revenue: €3.50b (down 11% from 2Q 2024). Net income: €120.0m (up €125.0m from 2Q 2024). Profit margin: 3.4% (up from net loss in 2Q 2024). Revenue missed analyst estimates by 5.4%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.分析記事 • Jul 11Investors Still Waiting For A Pull Back In Evonik Industries AG (ETR:EVK)With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Germany, you could be...分析記事 • Jun 26Evonik Industries (ETR:EVK) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Jun 11Evonik Industries' (ETR:EVK) Returns Have Hit A WallTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...Upcoming Dividend • May 22Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 29 May 2025. Payment date: 03 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (3.9%).Reported Earnings • May 13First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2025 results: EPS: €0.50 (up from €0.33 in 1Q 2024). Revenue: €3.78b (flat on 1Q 2024). Net income: €233.0m (up 49% from 1Q 2024). Profit margin: 6.2% (up from 4.1% in 1Q 2024). Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) exceeded analyst estimates by 48%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Declared Dividend • Mar 07Dividend of €1.17 announcedDividend of €1.17 is the same as last year. Ex-date: 29th May 2025 Payment date: 2nd June 2025 Dividend yield will be 5.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is not covered by earnings (246% earnings payout ratio). However, it is covered by cash flows (62% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 173% to bring the payout ratio under control. EPS is expected to grow by 158% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.New Risk • Mar 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 0% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (237% payout ratio). Large one-off items impacting financial results.お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.Reported Earnings • Mar 06Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: €0.48 (up from €1.00 loss in FY 2023). Revenue: €15.2b (flat on FY 2023). Net income: €222.0m (up €687.0m from FY 2023). Profit margin: 1.5% (up from net loss in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.新しいナラティブ • Nov 25Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins. Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.お知らせ • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025お知らせ • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.0%).Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.お知らせ • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.Reported Earnings • Mar 05Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.お知らせ • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.お知らせ • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 11Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024お知らせ • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).Major Estimate Revision • Jun 30Consensus EPS estimates fall by 20%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €17.0b to €16.7b. EPS estimate also fell from €1.14 per share to €0.914 per share. Net income forecast to grow 78% next year vs 38% decline forecast for Chemicals industry in Germany. Consensus price target down from €22.59 to €21.82. Share price rose 4.6% to €17.43 over the past week.お知らせ • Jun 09RAG Stiftung Not in Hurry to Cut Evonik StakeRAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung.Upcoming Dividend • May 25Upcoming dividend of €1.17 per share at 5.9% yieldEligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.7%).Major Estimate Revision • May 16Consensus EPS estimates fall by 12%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from €1.32 to €1.16 per share. Revenue forecast steady at €17.1b. Net income forecast to grow 117% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target down from €23.28 to €22.64. Share price was steady at €19.14 over the past week.配当金の支払いについて今日May 27 2026配当落ち日Jun 04 2026配当支払日Jun 08 20264 days 配当落ちから次の8 days 、次の配当を受け取るために購入する。決済の安定と成長配当データの取得安定した配当: EVKの1株当たり配当金は過去10年間安定しています。増加する配当: EVKの配当金支払額は過去10年間減少しています。配当利回り対市場Evonik Industries 配当利回り対市場EVK 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (EVK)5.8%市場下位25% (DE)1.5%市場トップ25% (DE)4.5%業界平均 (Chemicals)3.8%アナリスト予想 (EVK) (最長3年)4.7%注目すべき配当: EVKの配当金 ( 5.81% ) はGerman市場の配当金支払者の下位 25% ( 1.48% ) よりも高くなっています。高配当: EVKの配当金 ( 5.81% ) はGerman市場 ( 4.53% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: EVKは高い 配当性向 ( 296.3% ) のため、配当金の支払いは利益によって十分にカバーされていません。株主配当金キャッシュフローカバレッジ: EVKは合理的な 現金配当性向 ( 68.2% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 02:24終値2026/05/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Evonik Industries AG 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。31 アナリスト機関Anil ShenoyBarclaysAndreas HeineBarclaysSebastian BrayBerenberg28 その他のアナリストを表示
Declared Dividend • Feb 07Dividend reduced to €1.00Dividend of €1.00 is 15% lower than last year. Ex-date: 4th June 2026 Payment date: 8th June 2026 Dividend yield will be 6.7%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to decline by 19% over the next 3 years. A fall of 18% would increase the payout ratio to a potentially unsustainable range, which means the dividend may be at risk.
お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.
Upcoming Dividend • May 22Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 29 May 2025. Payment date: 03 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (3.9%).
Declared Dividend • Mar 07Dividend of €1.17 announcedDividend of €1.17 is the same as last year. Ex-date: 29th May 2025 Payment date: 2nd June 2025 Dividend yield will be 5.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is not covered by earnings (246% earnings payout ratio). However, it is covered by cash flows (62% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 173% to bring the payout ratio under control. EPS is expected to grow by 158% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.
Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.0%).
分析記事 • May 15There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) EarningsEvonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
お知らせ • May 12Vary Tech, Evonik and Supezet Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality Ppo and Circular NaphthaVary Tech, a global leader in solid waste resource utilization, together with Evonik and SupeZET, officially launched a full-industry chain process package for chemically recycling waste plastics into high-quality Plastic Pyrolysis Oil (PPO) and circular naphtha. The core technology is Vary Tech's oxygen-free pyrolysis, developed over 20 years and six iterations. With a single-unit capacity of 150 tons/day and over 8,000 operating hours annually, it ensures high front-end stability. The PPO then enters Evonik's proprietary Rocket module for upgrading and impurity removal, followed by SupeZET's advanced hydrogenation and fractionation for deep refining. The complete chain — feedstock pretreatment, continuous pyrolysis, deep purification, and product offtake — directly outputs circular naphtha and high-quality PPO meeting international petrochemical standards. This ensures seamless entry into global petrochemical and low-carbon fuel supply chains, removing technical barriers to the high-end circular economy. As the core engine, Vary Tech's oxygen-free pyrolysis technology offers broad feedstock compatibility. Beyond waste plastics, it has been applied to waste tires, oil sludge, industrial hazardous waste, medical waste, and new energy solid waste, with over 100 commercial pyrolysis lines delivered globally. While building chemical recycling, Vary Tech also leads in mechanical recycling. Leveraging 16 years of self-operated plant experience and its "high-end equipment manufacturing + industrial operation" dual-drive model, Vary Tech showcased its AI-powered intelligent home appliance dismantling system at the exhibition. Achieving 200 units per hour — a global efficiency record — the system delivers high-purity separation of all e-waste categories. Vary Tech has empowered Haier, TCL, and Midea, providing green recycling services for over 130 million obsolete appliances worldwide. From mechanical to chemical recycling, Vary Tech is integrating global supply chain resources to deliver scalable, economical, and sustainable technical solutions for global climate action and circular economy goals.
Reported Earnings • May 11First quarter 2026 earnings released: EPS: €0.27 (vs €0.50 in 1Q 2025)First quarter 2026 results: EPS: €0.27 (down from €0.50 in 1Q 2025). Revenue: €3.43b (down 9.3% from 1Q 2025). Net income: €125.0m (down 46% from 1Q 2025). Profit margin: 3.6% (down from 6.2% in 1Q 2025). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
ライブニュース • May 07Evonik Industries Stock Plunges 51% as Investors Await Crucial Earnings ReportEvonik Industries stock dropped 50.8% intraday on 5 May, reflecting a sharp loss of confidence ahead of its upcoming earnings release. The move highlights investor concern over profitability, operational headwinds and the resilience of the current dividend policy. The 8 May earnings announcement is seen as a key test of management’s outlook and plans through 2026. For you as an investor, the price shock signals that the market is bracing for potentially weak numbers or a reset in expectations, but without the earnings release yet, the exact triggers are not clear. The focus now is on whether management can provide a detailed picture of operational performance and explain how current conditions affect margins, cash flow and the dividend. The 2026 guidance will be especially important because it should show how Evonik plans to position its portfolio and manage costs over the medium term. Pay close attention to any commentary on capital allocation, possible changes to the payout, and the balance between investment and balance-sheet protection. This earnings call is likely to set the tone for how the stock is viewed until there is more concrete financial information.
ナラティブの更新 • May 03EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re RatingAnalysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.
ナラティブの更新 • Apr 19EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating PotentialAnalysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.
お知らせ • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.
ナラティブの更新 • Apr 03EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share PerformanceAnalysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €16.28, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 1.3% over the past three years.
ナラティブの更新 • Mar 20EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating PotentialThe analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.
New Risk • Mar 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 43% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (176% payout ratio). Large one-off items impacting financial results.
ナラティブの更新 • Mar 06EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker ViewsAnalysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.
ナラティブの更新 • Feb 20EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
Declared Dividend • Feb 07Dividend reduced to €1.00Dividend of €1.00 is 15% lower than last year. Ex-date: 4th June 2026 Payment date: 8th June 2026 Dividend yield will be 6.7%, which is higher than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. EPS is expected to decline by 19% over the next 3 years. A fall of 18% would increase the payout ratio to a potentially unsustainable range, which means the dividend may be at risk.
New Risk • Feb 06New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 5.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 5.3% per year for the foreseeable future. Minor Risks High level of debt (45% net debt to equity). Dividend is not well covered by earnings (dividend per share is over 5x earnings per share).
Reported Earnings • Feb 06Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: €1.36 (up from €0.48 in FY 2024). Revenue: €14.1b (down 7.2% from FY 2024). Net income: €634.0m (up 186% from FY 2024). Profit margin: 4.5% (up from 1.5% in FY 2024). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 2.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.
ナラティブの更新 • Feb 06EVK: Weaker Pricing Power Will Drive Lower Future Earnings ExpectationsAnalysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.
分析記事 • Feb 06Evonik Industries AG (ETR:EVK) Not Flying Under The RadarWhen close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
ナラティブの更新 • Jan 23EVK: Sector Caution And Margin Execution Will Shape Future Upside PotentialAnalysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.
ナラティブの更新 • Jan 08EVK: Pricing And Volume Execution Risk Will Pressure Future EarningsAnalysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
ナラティブの更新 • Dec 23EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside PotentialEvonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
ナラティブの更新 • Dec 09EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside PotentialThe analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.
分析記事 • Dec 04Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
ナラティブの更新 • Nov 24EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform CollaborationEvonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.
Price Target Changed • Nov 11Price target decreased by 10% to €16.45Down from €18.37, the current price target is an average from 13 analysts. New target price is 19% above last closing price of €13.80. Stock is down 23% over the past year. The company is forecast to post earnings per share of €0.76 for next year compared to €0.48 last year.
Major Estimate Revision • Nov 11Consensus EPS estimates fall by 23%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from €0.994 to €0.761 per share. Revenue forecast steady at €14.0b. Net income forecast to grow 351% next year vs 33% growth forecast for Chemicals industry in Germany. Consensus price target down from €17.63 to €16.45. Share price fell 3.6% to €13.80 over the past week.
New Risk • Nov 06New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Dividend per share is over 5x earnings per share. Cash payout ratio: 120% Minor Risks High level of debt (45% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin).
ナラティブの更新 • Nov 06EVK: Resilience And New Partnerships Will Drive Improved Revenue OutlookEvonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.
お知らせ • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026
Reported Earnings • Nov 05Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: €0.23 loss per share (down from €0.48 profit in 3Q 2024). Revenue: €3.39b (down 12% from 3Q 2024). Net loss: €106.0m (down 148% from profit in 3Q 2024). Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 8% per year.
分析記事 • Oct 30Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of InvestorsWith a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
ナラティブの更新 • Oct 23Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic MovesEvonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.
ナラティブの更新 • Oct 09Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.
お知らせ • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026
Price Target Changed • Sep 26Price target decreased by 7.0% to €18.91Down from €20.34, the current price target is an average from 13 analysts. New target price is 29% above last closing price of €14.69. Stock is down 31% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €0.48 last year.
お知らせ • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
ナラティブの更新 • Sep 25Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityEvonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.
分析記事 • Sep 13Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
ナラティブの更新 • Sep 04Singapore And Slovakia Facilities And EU Incentives Will Shape SustainabilityWith both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.
分析記事 • Aug 28At €16.68, Is It Time To Put Evonik Industries AG (ETR:EVK) On Your Watch List?Evonik Industries AG ( ETR:EVK ), is not the largest company out there, but it saw significant share price movement...
Reported Earnings • Aug 03Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: €0.26 (up from €0.011 loss in 2Q 2024). Revenue: €3.50b (down 11% from 2Q 2024). Net income: €120.0m (up €125.0m from 2Q 2024). Profit margin: 3.4% (up from net loss in 2Q 2024). Revenue missed analyst estimates by 5.4%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
分析記事 • Jul 11Investors Still Waiting For A Pull Back In Evonik Industries AG (ETR:EVK)With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Germany, you could be...
分析記事 • Jun 26Evonik Industries (ETR:EVK) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Jun 11Evonik Industries' (ETR:EVK) Returns Have Hit A WallTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Upcoming Dividend • May 22Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 29 May 2025. Payment date: 03 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (3.9%).
Reported Earnings • May 13First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2025 results: EPS: €0.50 (up from €0.33 in 1Q 2024). Revenue: €3.78b (flat on 1Q 2024). Net income: €233.0m (up 49% from 1Q 2024). Profit margin: 6.2% (up from 4.1% in 1Q 2024). Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) exceeded analyst estimates by 48%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Declared Dividend • Mar 07Dividend of €1.17 announcedDividend of €1.17 is the same as last year. Ex-date: 29th May 2025 Payment date: 2nd June 2025 Dividend yield will be 5.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is not covered by earnings (246% earnings payout ratio). However, it is covered by cash flows (62% cash payout ratio). The dividend has increased by an average of 1.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 173% to bring the payout ratio under control. EPS is expected to grow by 158% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
New Risk • Mar 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 0% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (237% payout ratio). Large one-off items impacting financial results.
お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.
Reported Earnings • Mar 06Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: €0.48 (up from €1.00 loss in FY 2023). Revenue: €15.2b (flat on FY 2023). Net income: €222.0m (up €687.0m from FY 2023). Profit margin: 1.5% (up from net loss in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
新しいナラティブ • Nov 25Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins.
Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: €0.48 (up from €0.21 loss in 3Q 2023). Revenue: €3.83b (up 1.6% from 3Q 2023). Net income: €223.0m (up €319.0m from 3Q 2023). Profit margin: 5.8% (up from net loss in 3Q 2023). Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025
お知らせ • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025
Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.0%).
Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.
Reported Earnings • Mar 05Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.
お知らせ • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.
Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024
お知らせ • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).
Major Estimate Revision • Jun 30Consensus EPS estimates fall by 20%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from €17.0b to €16.7b. EPS estimate also fell from €1.14 per share to €0.914 per share. Net income forecast to grow 78% next year vs 38% decline forecast for Chemicals industry in Germany. Consensus price target down from €22.59 to €21.82. Share price rose 4.6% to €17.43 over the past week.
お知らせ • Jun 09RAG Stiftung Not in Hurry to Cut Evonik StakeRAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung.
Upcoming Dividend • May 25Upcoming dividend of €1.17 per share at 5.9% yieldEligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.7%).
Major Estimate Revision • May 16Consensus EPS estimates fall by 12%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from €1.32 to €1.16 per share. Revenue forecast steady at €17.1b. Net income forecast to grow 117% next year vs 21% decline forecast for Chemicals industry in Germany. Consensus price target down from €23.28 to €22.64. Share price was steady at €19.14 over the past week.
